Diltiazem long-acting: Brand changed

Supply is ending for all strengths of Apo-Diltiazem brand long-acting diltiazem. We have secured alternatives for all 3 presentations.

25 January 2023

The entry for the 120 mg capsules is updated for the new contracted brand.

120 mg capsules 

From 1 December 2022, the funded brand of 120 mg capsules is Diltiazem CD Clinect (Pharmacode 2648172). 

This replaces the Accord brand 120 mg diltiazem hydrochloride capsules (Pharmacode 2625849) that we funded in 2021. The Accord brand was a temporary listing until we could contract a supplier after Apotex left the market.

The Accord brand product was not Medsafe approved and had to be prescribed and dispensed in line with section 29 of the Medicines Act. 

The Accord and Apo-Diltizem CD brands will be delisted on 01 June 2023. This will allow time for any product to move through the supply chain and be reimbursed. 

Schedule listing for diltiazem(external link)

180mg and 240mg capsules long-acting diltiazem

We listed Cardizem CD brand long-acting 180mg and 240mg diltiazem capsules on 1 October 2021. Apo-Diltizem CD were delisted from the Schedule on 1 February 2022. 

We consulted on this decision in February 2021. We appreciated the feedback we received. You can read the full decision and a discussion of the feedback we received on our website.

Decision to secure supply of 180 mg and 240 mg diltiazem hydrochloride capsules

Check the Schedule listing for pharmacodes(external link)

Thank you

We appreciate the time and effort of pharmacists and other health care professionals to support patients through brand changes for medicines.

Who to contact

If you have questions about the funding for diltiazem, email enquiry@pharmac.govt.nz